Literature DB >> 9025731

Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics.

O Sabri1, R Erkwoh, M Schreckenberger, U Cremerius, G Schulz, C Dickmann, H J Kaiser, E M Steinmeyer, H Sass, U Buell.   

Abstract

UNLABELLED: SPECT/PET studies in schizophrenia revealed inconsistent changes of regional cerebral blood flow (rCBF). Frontal hyperperfusion as well as hypoperfusion are described. This study was undertaken to investigate the relations between rCBF, psychopathology according to PANSS and effects of neuroleptic therapy.
METHODS: Twenty-four drug-naive acute patients with a first manifestation of schizophrenia were examined with 99mTc-HMPAO brain SPECT and assessed according to PANSS. Of these, 22 were controlled again after neuroleptic treatment. Following attenuation correction, region-to-cerebellar count ratios were obtained from 98 irregular regions of interest drawn in all slices (6.25 mm). The ratios were compared to 20 control subjects, and changes lying outside of 2 s.d. were considered abnormal.
RESULTS: In different drug-naive patients, hyperperfusion as well as hypoperfused patterns were found. In drug-naive patients, the seven subscores of positive symptoms (pos 1-7) in PANSS showed different correlations to rCBF: Formal thought disorders (pos 2) and grandiosity (pos 5) were positively correlated to bifrontal and bitemporal rCBF (r = +0.59 to +0.70). Delusional ideas (pos 1), hallucinatory behavior (pos 3) and suspiciousness (pos 6) demonstrated a negative correlation to bifrontal, cingulate, left temporal and left thalamic rCBF (r = -0.59 to -0.66). Stereotyped ideas (neg 7) as a negative symptom showed a negative correlation to left frontal, left temporal and left parietal rCBF (r = -0.59 to -0.65). No correlations were found between residual positive symptoms and rCBF after neuroleptic treatment and clinical improvement, but all negative symptoms (neg 1-7) had a negative correlation to bifrontal, bitemporal, cingulate, basal ganglia and thalamic rCBF (r = -0.59 to -0.74).
CONCLUSION: Our results illustrate that different positive symptoms are accompanied by different rCBF values: some induce hyperperfusion, others hypoperfusion. After therapy (and reduction of positive symptoms), only negative symptoms correlate exclusively to hypoperfusion. This may be the crucial factor in explaining inconsistencies of past results in perfusion pattern in drug-naive schizophrenic patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9025731

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

1.  Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI.

Authors:  Amy Pinkham; James Loughead; Kosha Ruparel; Wen-Chau Wu; Eve Overton; Raquel Gur; Ruben Gur
Journal:  Psychiatry Res       Date:  2011-08-09       Impact factor: 3.222

2.  Comparison of Classical and Clozapine Treatment on Schizophrenia Using Positive and Negative Syndrome Scale of Schizophrenia (PANSS) and SPECT Imaging.

Authors:  Mohammad Sharafi
Journal:  Int J Med Sci       Date:  2005-05-10       Impact factor: 3.738

Review 3.  Neurobiological background of negative symptoms.

Authors:  Silvana Galderisi; Eleonora Merlotti; Armida Mucci
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-03-24       Impact factor: 5.270

4.  Fronto-temporal dysfunction in schizophrenia: A selective review.

Authors:  John P John
Journal:  Indian J Psychiatry       Date:  2009 Jul-Sep       Impact factor: 1.759

5.  Deletion of the STOP gene, a microtubule stabilizing factor, leads only to discrete cerebral metabolic changes in mice.

Authors:  Ryosuke Hanaya; Estelle Koning; Arielle Ferrandon; Annie Schweitzer; Annie Andrieux; Astrid Nehlig
Journal:  J Neurosci Res       Date:  2008-03       Impact factor: 4.164

Review 6.  Spontaneous low-frequency fluctuations in the BOLD signal in schizophrenic patients: anomalies in the default network.

Authors:  Robyn L Bluhm; Jodi Miller; Ruth A Lanius; Elizabeth A Osuch; Kristine Boksman; R W J Neufeld; Jean Théberge; Betsy Schaefer; Peter Williamson
Journal:  Schizophr Bull       Date:  2007-06-07       Impact factor: 9.306

7.  Reduced auditory segmentation potentials in first-episode schizophrenia.

Authors:  Brian A Coffman; Sarah M Haigh; Timothy K Murphy; Justin Leiter-Mcbeth; Dean F Salisbury
Journal:  Schizophr Res       Date:  2017-10-22       Impact factor: 4.939

8.  Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: an in vivo localized (1)H MRS study.

Authors:  Isabelle Iltis; Dee M Koski; Lynn E Eberly; Christopher D Nelson; Dinesh K Deelchand; Julien Valette; Kamil Ugurbil; Kelvin O Lim; Pierre-Gilles Henry
Journal:  NMR Biomed       Date:  2009-08       Impact factor: 4.044

9.  A review of SPECT studies in psychiatry in China.

Authors:  Shenxun Shi; Liang Shu
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

10.  Functional genomics indicate that schizophrenia may be an adult vascular-ischemic disorder.

Authors:  H W Moises; D Wollschläger; H Binder
Journal:  Transl Psychiatry       Date:  2015-08-11       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.